JP2014511884A5 - - Google Patents

Download PDF

Info

Publication number
JP2014511884A5
JP2014511884A5 JP2014505543A JP2014505543A JP2014511884A5 JP 2014511884 A5 JP2014511884 A5 JP 2014511884A5 JP 2014505543 A JP2014505543 A JP 2014505543A JP 2014505543 A JP2014505543 A JP 2014505543A JP 2014511884 A5 JP2014511884 A5 JP 2014511884A5
Authority
JP
Japan
Prior art keywords
pyrazolo
quinolin
methoxy
amine
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2014505543A
Other languages
English (en)
Japanese (ja)
Other versions
JP6278406B2 (ja
JP2014511884A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/EP2012/001736 external-priority patent/WO2012143143A1/en
Publication of JP2014511884A publication Critical patent/JP2014511884A/ja
Publication of JP2014511884A5 publication Critical patent/JP2014511884A5/ja
Application granted granted Critical
Publication of JP6278406B2 publication Critical patent/JP6278406B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2014505543A 2011-04-21 2012-04-23 キナーゼ・インヒビターとしての複素環化合物 Active JP6278406B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161517581P 2011-04-21 2011-04-21
US61/517,581 2011-04-21
PCT/EP2012/001736 WO2012143143A1 (en) 2011-04-21 2012-04-23 Heterocyclic compounds as kinase inhibitors

Publications (3)

Publication Number Publication Date
JP2014511884A JP2014511884A (ja) 2014-05-19
JP2014511884A5 true JP2014511884A5 (https=) 2016-10-27
JP6278406B2 JP6278406B2 (ja) 2018-02-14

Family

ID=46001141

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2014505543A Active JP6278406B2 (ja) 2011-04-21 2012-04-23 キナーゼ・インヒビターとしての複素環化合物

Country Status (25)

Country Link
US (1) US9499535B2 (https=)
EP (1) EP2699572B1 (https=)
JP (1) JP6278406B2 (https=)
KR (1) KR101649610B1 (https=)
CN (1) CN103717597B (https=)
AP (1) AP2013007252A0 (https=)
AU (1) AU2012244549B2 (https=)
BR (1) BR112013026744B1 (https=)
CA (1) CA2831680C (https=)
CL (1) CL2013003052A1 (https=)
CO (1) CO6831983A2 (https=)
CR (1) CR20130537A (https=)
CU (1) CU20130144A7 (https=)
EA (1) EA034193B1 (https=)
EC (1) ECSP13012984A (https=)
GT (1) GT201300259A (https=)
IL (1) IL228967B (https=)
MA (1) MA35123B1 (https=)
MX (1) MX365784B (https=)
PE (1) PE20140927A1 (https=)
PH (1) PH12013502184A1 (https=)
SG (1) SG194216A1 (https=)
TN (1) TN2013000422A1 (https=)
TW (1) TWI557121B (https=)
WO (1) WO2012143143A1 (https=)

Families Citing this family (47)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BR112013027096A2 (pt) 2011-04-21 2016-12-27 Gilead Sciences Inc compostos de benzotiazol e seu uso farmacêutico
EP2699572B1 (en) 2011-04-21 2016-08-10 Origenis GmbH Heterocyclic compounds as kinase inhibitors
WO2013103724A1 (en) 2012-01-04 2013-07-11 Gilead Sciences, Inc. 2- (tert - butoxy) -2- (7 -methylquinolin- 6 - yl) acetic acid derivatives for treating aids
US9284323B2 (en) 2012-01-04 2016-03-15 Gilead Sciences, Inc. Naphthalene acetic acid derivatives against HIV infection
AR090650A1 (es) 2012-04-12 2014-11-26 Alcon Res Ltd Tratamiento para respuestas inflamatorias inducidas por microbios en el ojo
WO2014001973A1 (en) 2012-06-29 2014-01-03 Pfizer Inc. NOVEL 4-(SUBSTITUTED-AMINO)-7H-PYRROLO[2,3-d]PYRIMIDINES AS LRRK2 INHIBITORS
CN112587671A (zh) 2012-07-18 2021-04-02 博笛生物科技有限公司 癌症的靶向免疫治疗
US10000482B2 (en) 2012-10-19 2018-06-19 Origenis Gmbh Kinase inhibitors
TW201444850A (zh) * 2013-03-15 2014-12-01 Ipsen Pharma Sas 巨環lrrk2激酶抑制劑
WO2015026683A1 (en) * 2013-08-22 2015-02-26 Merck Sharp & Dohme Corp. Compounds inhibiting leucine-rich repeat kinase enzyme activity
JP6992960B2 (ja) * 2013-12-02 2022-02-03 ベルゲンビオ アーエスアー キナーゼ阻害剤の用途
JP6487921B2 (ja) 2013-12-17 2019-03-20 ファイザー・インク LRRK2阻害薬としての新規の3,4−二置換−1H−ピロロ[2,3−b]ピリジンおよび4,5−二置換−7H−ピロロ[2,3−c]ピリダジン
CN105899539B (zh) 2014-01-10 2021-11-09 博笛生物科技有限公司 用于免疫疗法的化合物和组合物
EP3166976B2 (en) 2014-07-09 2026-04-08 Birdie Biopharmaceuticals Inc. Anti-pd-l1 combinations for treating tumors
EP3166637B1 (en) 2014-07-10 2020-01-29 The J. David Gladstone Institutes Compositions and methods for treating dengue virus infection
CN112587672A (zh) 2014-09-01 2021-04-02 博笛生物科技有限公司 用于治疗肿瘤的抗-pd-l1结合物
EP3662751B1 (en) * 2015-05-26 2021-10-13 Kaohsiung Medical University Pyrazolo[4,3-c]quinoline derivatives for inhibition of b-glucuronidase
KR102161364B1 (ko) * 2015-09-14 2020-09-29 화이자 인코포레이티드 LRRK2 억제제로서 이미다조[4,5-c]퀴놀린 및 이미다조[4,5-c][1,5]나프티리딘 유도체
CN105664178B (zh) * 2015-09-24 2019-08-20 洪健 Syk作为肝纤维化/硬化治疗靶点的应用
CN106943596A (zh) 2016-01-07 2017-07-14 博笛生物科技(北京)有限公司 用于治疗肿瘤的抗-cd20组合
CN115350279A (zh) 2016-01-07 2022-11-18 博笛生物科技有限公司 用于治疗肿瘤的抗-her2组合
CN115252792A (zh) 2016-01-07 2022-11-01 博笛生物科技有限公司 用于治疗肿瘤的抗-egfr组合
US10034861B2 (en) 2016-07-04 2018-07-31 H. Lundbeck A/S 1H-pyrazolo[4,3-b]pyridines as PDE1 inhibitors
SMT202100225T1 (it) 2016-12-20 2021-05-07 Astrazeneca Ab Composti di ammino-triazolopiridina e loro uso nel trattamento del cancro
US10882867B2 (en) * 2017-03-16 2021-01-05 Celgene Car Llc Forms and compositions of a MK2 inhibitor
JP7108018B2 (ja) 2017-04-17 2022-07-27 イエール ユニバーシティ 急性肺傷害を処置または予防する化合物、組成物および方法
CN118515666A (zh) * 2017-04-27 2024-08-20 博笛生物科技有限公司 2-氨基-喹啉衍生物
IL312120B2 (en) 2017-06-23 2025-06-01 Birdie Biopharmaceuticals Inc Pharmaceutical compositions
AR113926A1 (es) 2017-12-14 2020-07-01 H Lundbeck As Derivados de 1h-pirazolo[4,3-b]piridinas
MX2020006174A (es) 2017-12-14 2022-09-27 H Lundbeck As Tratamientos de combinación que comprenden la administración de 1h-pirazol[4,3-b]piridinas.
WO2019121840A1 (en) 2017-12-20 2019-06-27 H. Lundbeck A/S Pyrazolo[3,4-b]pyridines and imidazo[1,5-b]pyridazines as pde1 inhibitors
PE20210160A1 (es) * 2018-04-25 2021-01-26 Innate Tumor Immunity Inc Moduladores de nlrp3
JP2020132986A (ja) * 2019-02-25 2020-08-31 東京エレクトロン株式会社 成膜用組成物および成膜方法
CN116854706B (zh) * 2019-04-18 2025-11-04 四川科伦博泰生物医药股份有限公司 稠环化合物、其制备方法及用途
JP7796007B2 (ja) * 2019-09-13 2026-01-08 オリゲニス ゲーエムベーハー 例えば自己免疫疾患の処置のための、LRRK2、NUAK1および/またはTYK2キナーゼモジュレータとしての1,4-ジヒドロベンゾ[d]ピラゾロ[3,4-f][1,3]ジアゼピン誘導体および関連する化合物
JP2022548581A (ja) * 2019-09-13 2022-11-21 オリゲニス ゲーエムベーハー 例えば自己免疫疾患の処置のための、LRRK2、NUAK1および/またはTYK2キナーゼモジュレータとしての1,4-ジヒドロベンゾ[d]ピラゾロ[3,4-f][1,3]ジアゼピン誘導体および関連する化合物
JP2023502252A (ja) * 2019-11-20 2023-01-23 イエール ユニバーシティ 虚血再灌流傷害および/または肺傷害を処置するための化合物、組成物および方法
WO2021207141A1 (en) * 2020-04-06 2021-10-14 The Regents Of The University Of Colorado, A Body Corporate METHODS OF USING NEUROKININ-1 RECEPTOR (NK-1R) ANTAGONISTS TO TREAT β-CORONAVIRUS INFECTION INCLUDING SARS-COV-2 INFECTION AND/OR COVID-19 DISEASE
US12569481B2 (en) 2020-06-12 2026-03-10 Vanderbilt University Methods of treatment for gastrointestinal motility disorders
JP7752675B2 (ja) * 2020-07-06 2025-10-10 アカデミー オブ ミリタリー メディカル サイエンシズ ウイルスに対するタウロリジンの使用
WO2022079250A1 (en) * 2020-10-16 2022-04-21 Merck Patent Gmbh Compounds for the treatment of viral infections
CN112138015B (zh) * 2020-10-22 2022-08-05 合肥博思科创医药科技有限公司 三苄糖苷在治疗微循环障碍引起的皮肤疾病中的应用
CA3202773A1 (en) * 2020-10-26 2022-05-05 Neuron23, Inc. Methods of treatment and diagnosis of parkinson's disease associated with wild-type lrrk2
WO2022166548A1 (zh) * 2021-02-03 2022-08-11 苏州欧康维视生物科技有限公司 吡唑取代的咪唑并[1,2-a]喹喔啉衍生物的盐型及晶型
WO2023076404A1 (en) 2021-10-27 2023-05-04 Aria Pharmaceuticals, Inc. Methods for treating systemic lupus erythematosus
CN114931573A (zh) * 2022-01-13 2022-08-23 浙江中医药大学 依普黄酮在抑制nlrp3炎症小体活化中的应用
US11981676B1 (en) 2024-01-16 2024-05-14 King Faisal University Pyrazolo[4,3-c][2,6]naphthyridines as CK2 inhibitors

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0022078B1 (de) 1979-06-21 1984-07-25 Ciba-Geigy Ag Pyrazolochinoline, Verfahren zu ihrer Herstellung, und pharmazeutische Präparate enthaltend diese Verbindungen
US5360720A (en) 1993-10-08 1994-11-01 Alcon Laboratories, Inc. Method of preparing human conjunctival mast cells for mast cell stabilization assays
US5723608A (en) 1996-12-31 1998-03-03 Neurogen Corporation 3-aryl substituted pyrazolo 4,3-d!pyrimidine derivatives; corticotropin-releasing factor receptor (CRF1) specific ligands
US6531475B1 (en) 1998-11-12 2003-03-11 Neurocrine Biosciences, Inc. CRF receptor antagonists and methods relating thereto
GB0106661D0 (en) 2001-03-16 2001-05-09 Pfizer Ltd Pharmaceutically active compounds
TW200526656A (en) * 2003-10-03 2005-08-16 3M Innovative Properties Co Pyrazolopyridines and analogs thereof
US7544697B2 (en) * 2003-10-03 2009-06-09 Coley Pharmaceutical Group, Inc. Pyrazolopyridines and analogs thereof
US7384930B2 (en) 2004-11-03 2008-06-10 Bristol-Myers Squibb Company Constrained compounds as CGRP-receptor antagonists
JP2008538119A (ja) 2005-04-01 2008-10-09 コーリー ファーマシューティカル グループ,インコーポレーテッド ピラゾロ[3,4−c]キノリン類、ピラゾロ[3,4−c]ナフチリジン類、これらの類似体、および方法
JP2008538550A (ja) 2005-04-01 2008-10-30 コーリー ファーマシューティカル グループ,インコーポレイテッド ウイルス感染および腫瘍性疾患を処置するためのサイトカイン生合成の調節因子としての1−置換ピラゾロ(3,4−c)環状化合物
WO2008144253A1 (en) * 2007-05-14 2008-11-27 Irm Llc Protein kinase inhibitors and methods for using thereof
JP5748659B2 (ja) * 2008-06-10 2015-07-15 アッヴィ・インコーポレイテッド 新規な三環式化合物
EP2303890A4 (en) 2008-06-19 2012-04-11 Progenics Pharm Inc INHIBITORS OF PHOSPHATIDYLINOSITE-3-KINASE
TW201024297A (en) * 2008-09-10 2010-07-01 Kalypsys Inc Heterocyclic inhibitors of histamine receptors for the treatment of disease
JP2010143829A (ja) * 2008-12-16 2010-07-01 Dainippon Sumitomo Pharma Co Ltd 新規なイミダゾキノリン誘導体
MX2011009807A (es) * 2009-03-19 2011-09-29 Medical Res Council Technology Compuestos.
PE20121336A1 (es) 2009-12-01 2012-11-03 Abbvie Inc Nuevos compuestos triciclicos
KR20120102724A (ko) 2009-12-01 2012-09-18 아보트 러보러터리즈 신규한 트리사이클릭 화합물
TW201204727A (en) 2010-03-10 2012-02-01 Kalypsys Inc Heterocyclic inhibitors of histamine receptors for the treatment of disease
EP2699572B1 (en) 2011-04-21 2016-08-10 Origenis GmbH Heterocyclic compounds as kinase inhibitors
US10000482B2 (en) 2012-10-19 2018-06-19 Origenis Gmbh Kinase inhibitors

Similar Documents

Publication Publication Date Title
JP2014511884A5 (https=)
JP7650854B2 (ja) ユビキチン特異的プロテアーゼ1阻害剤としてのプリノン
US10995078B2 (en) Compounds and compositions for inhibition of FASN
AU2017382185C9 (en) Pyrazole derivatives as MALT1 inhibitors
JP2014511885A5 (https=)
JP5134548B2 (ja) 過剰増殖性疾患の処置のためのErbBI型受容体チロシンキナーゼ阻害剤としてのN4−フェニルキナゾリン−4−アミン誘導体および関連化合物
JP6258331B2 (ja) キナーゼ阻害剤としてのアミノ−キノリン
JP2020514267A5 (https=)
WO2015171527A1 (en) Pyrazolopyridine pyrazolopyrimidine and related compounds
JP2016500671A5 (https=)
WO2015031613A1 (en) Biaryl acetamide compounds and methods of use thereof
WO2015038417A1 (en) Compounds for regulating fak and/or src pathways
WO2014060113A1 (en) Novel kinase inhibitors
CN119095839A (zh) 作为Mas相关G蛋白受体X2的调节剂和相关产物的喹啉衍生物
CA3250387A1 (en) Tetrahydropyrido[3,4-D]pyrimidine compounds used as HPK1 inhibitors
TW202529739A (zh) Parg之抑制劑
HK40018685A (en) 2-hydroxy-1-{4-[(4-phenylphenyl)carbonyl]piperazin-1-yl}ethan-1-one derivatives and related compounds as fatty acid synthase (fasn) inhibitors for the treatment of cancer
HK40018685B (en) 2-hydroxy-1-{4-[(4-phenylphenyl)carbonyl]piperazin-1-yl}ethan-1-one derivatives and related compounds as fatty acid synthase (fasn) inhibitors for the treatment of cancer
HK1220409B (en) 2-hydroxy-1-{4-[(4-phenylphenyl)carbonyl]piperazin-1-yl}ethan-1-one derivatives and related compounds as fatty acid synthase (fasn) inhibitors for the treatment of cancer